| Serological Study of Dengue and Characterization of Immune Response in Ten Endemic and Non-Endemic Cities in Mexico (NCT04947111) | Mexican Society of Public Health | 2022-04-30 |
| Study of AT-752 in Healthy Subjects in a Dengue Human Challenge Model (NCT05366439) | Atea Pharmaceuticals, Inc. | 2022-04-22 |
| Dengue 4 Human Infection Model (Dengue CVD 11000; DHIM-4) (NCT05268302) | University of Maryland, Baltimore | 2022-02-28 |
| An Evaluation of Repeated Oral Doses of JNJ-64281802 Against DENV-3 Challenge (NCT05048875) | National Institute of Allergy and Infectious Diseases (NIAID) | 2022-02-03 |
| A Study of JNJ-64281802 in Participants With Confirmed Dengue Fever (NCT04906980) | Janssen Research & Development, LLC | 2022-01-24 |
| Dengue Controlled Human Infection Model in Dhaka, Bangladesh (NCT05229354) | Beth Kirkpatrick | 2021-12-11 |
| A Phase-I Study of a Nanoparticle-based Peptide Vaccine Against Dengue Virus (NCT04935801) | Gylden Pharma Ltd | 2021-08-02 |
| Study on the Risks of Symptomatic Dengue on Pregnancy (NCT04826081) | Centre Hospitalier Universitaire de la Réunion | 2021-06-15 |
| Dengue Vaccine Strategy in Children Aged 9 to 17 Years in the French Caribbean (NCT04839757) | University Hospital Center of Martinique | 2021-06-03 |
| Validation of a CDSA Strategy to Reduce Antibiotic Prescription in Senegal (NCT05050825) | Foundation for Innovative New Diagnostics, Switzerland | 2021-05-03 |
| Study of AT-752 in Healthy Subjects (NCT04722627) | Atea Pharmaceuticals, Inc. | 2021-03-09 |
| Effects of a Serious Game on Knowledge, Attitude and Practice in Vector Control and Dengue Prevention Among Adults in Primary Care (NCT05307484) | SingHealth Polyclinics | 2021-03-03 |
| Virological and Immunological Determinants of Arbovirus Infection in New Caledonia (NCT04619823) | Institut Pasteur | 2021-02-15 |
| Infection Tracking in Travellers. The Project Aims to Identify Profiles of Travel-associated Illness and to Follow up on Long-term Sequelae of Arboviral Infections and Malaria (NCT04672577) | Patricia Schlagenhauf | 2021-01-30 |
| Characterizing Humoral Immune Response to Mosquito Bites (NCT04478370) | University of Oxford | 2021-01-21 |
| ADVP005; Dengue CVD 12000 - Dengue-1-Virus Live Virus Human Challenge (DENV-1-LVHC) (NCT04786457) | University of Maryland, Baltimore | 2020-11-30 |
| Quantifying the Epidemiological Impact of Targeted Indoor Residual Spraying on Aedes-borne Diseases (NCT04343521) | Emory University | 2020-11-03 |
| Demonstration of an Electronic Clinical Decision Support Module for Dengue in Burkina Faso (NCT04582474) | Foundation for Innovative New Diagnostics, Switzerland | 2020-09-10 |
| Dengue 3 Human Infection Model (DENV-3) (NCT04298138) | State University of New York - Upstate Medical University | 2020-08-03 |
| Metformin in Dengue With Obesity (NCT04377451) | Oxford University Clinical Research Unit, Vietnam | 2020-07-27 |
| Genetic Evolution of Arboviruses in New Caledonia Between 1995 and 2024 and Impact of Wolbachia (NCT04615364) | Institut Pasteur | 2020-07-17 |
| Safety Study of Dengushield in Healthy Adults (NCT03883620) | Serum Institute of India Pvt. Ltd. | 2019-03-22 |
| Expansion of a Dengue-1 Live Virus Human Challenge (NCT03869060) | State University of New York - Upstate Medical University | 2019-03-11 |
| Pilot Study to Detect DENGUE Virus in Sperm (NCT03612609) | University Hospital, Toulouse | 2019-02-06 |
| Sustainable Reduction of Dengue in Colombia: Vector Breeding Site Intervention With an Insecticidal Coating (NCT06268691) | Rocio Cardenas Sanchez | 2019-02-04 |
| Clinical Trial of the Safety and Immunogenicity of a Tetravalent Dengue Virus Vaccine Admixture TV005 in the Elderly Aged 50-70 Years in Taiwan (NCT04133987) | National Taiwan University Hospital | 2018-10-15 |
| Combating Dengue With Innovative, Paradigm-shift-Strategies: Early Dengue Surveillance in Adult Aedes Mosquitoes (NCT03799237) | Jonathan Liew Wee Kent | 2018-10-01 |
| Defining Skin Immunity of a Bite of Key Insect Vectors in Humans (NCT03641339) | National Institute of Allergy and Infectious Diseases (NIAID) | 2018-09-05 |
| Bedside Ultrasound Predicts Progression of Severity of Disease in Dengue Fever (NCT03632486) | Timothy Gleeson | 2018-08-13 |
| Immunogenicity and Safety of Tetravalent Dengue Vaccine (TDV) Administered With a Yellow Fever Vaccine in Adults (NCT03342898) | Takeda | 2018-02-28 |
| Evaluation of the Efficacy of the Live Attenuated Tetravalent Dengue Vaccine Against DENV-2 and DENV-3 Challenge (NCT03416036) | National Institute of Allergy and Infectious Diseases (NIAID) | 2017-11-28 |
| Applying Wolbachia to Eliminate Dengue (NCT03055585) | Gadjah Mada University | 2017-11-08 |
| Impact of Wolbachia Deployment on Arboviral Disease Incidence in Medellin and Bello, Colombia (NCT03631719) | Universidad de Antioquia | 2017-10-25 |
| Dengue Effectiveness Study in the Philippines (NCT03803618) | University of the Philippines | 2017-09-01 |
| Assessing the Effectiveness of Sanofi Pasteur's Dengue Vaccine (Dengvaxia) Against Hospitalization and Symptomatic Infection in the State of Parana - Brazil (NCT03960385) | Albert B. Sabin Vaccine Institute | 2017-08-01 |
| Clinical Trial of Diagnostic Tests and Clinical Algorithms for Dengue in Febrile Subjects in Endemic Areas in Colombia (NCT04063774) | Lyda Osorio | 2016-12-27 |
| Dengue Serostatus Study in the Philippines (NCT03465254) | University of the Philippines | 2016-11-01 |
| Safety of Paracetamol as Antipyretic in Treatment of Dengue Infection in Adults (NCT02833584) | Phramongkutklao College of Medicine and Hospital | 2016-09-01 |
| Evaluating the Safety and Protective Efficacy of a Single Dose of the Live Attenuated Tetravalent Dengue Vaccine TV005 to Protect Against Infection With rDEN3Δ30 (NCT02873260) | National Institute of Allergy and Infectious Diseases (NIAID) | 2016-08-01 |
| This Study Will Describe the Burden of DENgue Fever Virus (DENV) Illness Among Household Members Aged 6 Months to 50 Years of Selected Communities in Latin America and Southeast Asia (NCT02766088) | GlaxoSmithKline | 2016-07-14 |
| The Evaluation of Potential Zika, Chikungunya, and Dengue Infections in Mexico (NCT02831699) | Mexican Emerging Infectious Diseases Clinical Research Network | 2016-06-21 |
| A Cohort Study to Determine the Incidence of Dengue Fever and to Build Capacity for Dengue Vaccine Trials in Dengue-endemic Regions of South Asia (NCT02570152) | GlaxoSmithKline | 2016-06-01 |
| Safety and Immunogenicity of the Dengue Virus Vaccine TV005 (TetraVax-DV TV005) in Healthy Adults, Adolescents, and Children in Dhaka, Bangladesh (NCT02678455) | National Institute of Allergy and Infectious Diseases (NIAID) | 2016-03-01 |
| Phase III Trial to Evaluate Efficacy and Safety of a Tetravalent Dengue Vaccine (NCT02406729) | Butantan Institute | 2016-02-22 |
| Evaluating the Safety and Immunogenicity of a Tetravalent Dengue Vaccine (TetraVax-DV) TV005 in Flavivirus-Naive Adults 50 to 70 Years of Age (NCT02879266) | National Institute of Allergy and Infectious Diseases (NIAID) | 2016-02-01 |
| TDENV PIV and LAV Dengue Prime-boost Strategy Using AS03B Adjuvant (NCT03110952) | U.S. Army Medical Research and Development Command | 2016-01-01 |
| Prevalence of Hyponatremia in Dengue Infected Patients: Relationship With Systemic Inflammation. (NCT06109532) | Hospital Nacional Profesor Alejandro Posadas | 2016-01-01 |
| Diagnosing Dengue: Evaluating the Utility of Oral Fluid for Dengue Diagnosis (NCT02435615) | University of Miami | 2016-01-01 |
| Assessment of a Dengue-1-Virus-Live Virus Human Challenge - (DENV-1-LVHC) Virus Strain (NCT02372175) | U.S. Army Medical Research and Development Command | 2015-10-01 |
| The Use of Biomarkers in Predicting Dengue Outcome (NCT02606019) | Universiti Tunku Abdul Rahman | 2015-10-01 |
| Evaluating the Safety and Protective Efficacy of a Single Dose of a Trivalent Live Attenuated Dengue Vaccine to Protect Against Infection With DENV-2 (NCT02433652) | National Institute of Allergy and Infectious Diseases (NIAID) | 2015-09-01 |
| Study of Varying Injection Schedules of TDENV-PIV Vaccine With AS03B Adjuvant and Placebo in Healthy US Adults (NCT02421367) | U.S. Army Medical Research and Development Command | 2015-08-01 |
| Evaluating the Safety, Tolerability, and Immunogenicity of a Tetravalent Dengue Vaccine (V180) in Healthy Adults Who Previously Received a Live-Attenuated Tetravalent Vaccine (TV003 or TV005) (NCT02450838) | National Institute of Allergy and Infectious Diseases (NIAID) | 2015-04-01 |
| Ability of Bedside Ultrasound to Predict Progression of Severity of Disease in Dengue Fever (NCT02134652) | University of Massachusetts, Worcester | 2015-01-01 |
| Evaluation of the Safety and Efficacy of a Single Dose of a Dengue Vaccine (TV005) in Healthy Adults (NCT02317900) | National Institute of Allergy and Infectious Diseases (NIAID) | 2014-12-01 |
| TDENV PIV and LAV Dengue Prime-boost Strategy (NCT02239614) | U.S. Army Medical Research and Development Command | 2014-12-01 |
| An Epidemiological Surveillance Study to Evaluate the Incidence of Dengue in Brazil (NCT01751139) | GlaxoSmithKline | 2014-02-18 |
| Immunologic Mechanisms of Immune Interference and/or Cross-Neutralizing Immunity After CYD Tetravalent Dengue Vaccine (NCT01943825) | Sanofi Pasteur, a Sanofi Company | 2013-11-05 |
| Evaluating the Safety and Effectiveness of a Dengue Virus Vaccine in Healthy Adults (NCT02021968) | National Institute of Allergy and Infectious Diseases (NIAID) | 2013-11-01 |
| Phase II Trial to Evaluate Safety and Immunogenicity of a Dengue 1,2,3,4 (Attenuated) Vaccine (NCT01696422) | Butantan Institute | 2013-10-01 |
| Long-Term Study of Hospitalized Dengue & Safety in Thai Children Included in a Tetravalent Dengue Vaccine Efficacy Study (NCT01983553) | Sanofi Pasteur, a Sanofi Company | 2013-09-10 |
| Pharmacological Effect of Carica Papaya Leaves Mother Tincture in Healthy Individuals Blood Parameter (NCT02016027) | Fr Muller Homoeopathic Medical College | 2013-09-01 |
| Evaluating the Safety and Immune Response to a Dengue Virus Vaccine in Healthy Adults (NCT01931176) | National Institute of Allergy and Infectious Diseases (NIAID) | 2013-06-01 |
| Procleix® Dengue Virus Assay Testing of Individual Donor Samples From Puerto Rican and US Blood Donors - CTS (NCT01702272) | Gen-Probe, Incorporated | 2013-01-01 |
| Evaluating the Safety and Immune Response to Two Doses of a Dengue Virus Vaccine Administered 12 Months Apart (NCT01782300) | National Institute of Allergy and Infectious Diseases (NIAID) | 2013-01-01 |
| Procleix® Dengue Virus Assay Testing of Individual Donor Samples From Puerto Rican Blood Donors - American Red Cross (NCT01656174) | Gen-Probe, Incorporated | 2012-08-01 |
| Materno-fetal Consequences of Symptomatic Dengue in Pregnant Wowen in French Guiana (NCT04989673) | Centre Hospitalier de Cayenne | 2012-07-11 |
| Study of a Tetravalent Dengue Vaccine in Healthy Adult Subjects Aged 18 to 45 Years in India (NCT01550289) | Sanofi Pasteur, a Sanofi Company | 2012-03-01 |
| Insecticidal School Uniforms for Dengue Prevention in Thailand (NCT01563640) | Umeå University | 2012-03-01 |
| Immune Response to Different Schedules of a Tetravalent Dengue Vaccine Given With or Without Yellow Fever Vaccine (NCT01488890) | Sanofi Pasteur, a Sanofi Company | 2011-12-06 |
| Evaluating the Safety and Immune Response to Two Admixtures of a Tetravalent Dengue Virus Vaccine (NCT01506570) | National Institute of Allergy and Infectious Diseases (NIAID) | 2011-12-01 |
| Study of Yellow Fever Vaccine Administered With Tetravalent Dengue Vaccine in Healthy Toddlers (NCT01436396) | Sanofi Pasteur, a Sanofi Company | 2011-09-07 |
| Study to Evaluate the Incidence, Clinical Characteristics and Economic Burden of Dengue in Brazilian Children (NCT01391819) | GlaxoSmithKline | 2011-09-06 |
| Prospective Dengue Seroprevalence Study in 5 to 10 Year-old Children (NCT01477671) | Sanofi Pasteur, a Sanofi Company | 2011-09-01 |
| Evaluating the Safety and Immune Response to Two Admixtures of a Tetravalent Dengue Virus Vaccine (NCT01436422) | National Institute of Allergy and Infectious Diseases (NIAID) | 2011-08-01 |
| Study of a Booster Injection of Pentaxim™ Vaccine Administered With Dengue Vaccine in Healthy Toddlers (NCT01411241) | Sanofi Pasteur, a Sanofi Company | 2011-07-18 |
| Study of a Novel Tetravalent Dengue Vaccine in Healthy Children and Adolescents Aged 9 to 16 Years in Latin America (NCT01374516) | Sanofi Pasteur, a Sanofi Company | 2011-06-08 |
| Study of a Novel Tetravalent Dengue Vaccine in Healthy Children Aged 2 to 14 Years in Asia (NCT01373281) | Sanofi Pasteur, a Sanofi Company | 2011-06-03 |
| Dengue Seroprevalence Study in Blood Donors in the French West Indies (NCT01104740) | Etablissement Français du Sang, Martinique | 2011-05-01 |
| Study of CYD Dengue Vaccine in Healthy Children and Adolescents in South America (NCT01187433) | Sanofi Pasteur, a Sanofi Company | 2010-08-01 |
| Evaluation of the Safety and Immune Response of Five Admixtures of a Tetravalent Dengue Virus Vaccine (NCT01072786) | National Institute of Allergy and Infectious Diseases (NIAID) | 2010-07-01 |
| A Study of Balapiravir in Patients With Dengue Virus Infection (NCT01096576) | Hoffmann-La Roche | 2010-07-01 |
| Cohort of Patients Infected by an Arbovirus (NCT01099852) | University Hospital Center of Martinique | 2010-06-01 |
| Tetravalent Chimeric Dengue Vaccine Trial (NCT01110551) | National Institute of Allergy and Infectious Diseases (NIAID) | 2010-05-01 |
| Immunogenicity and Safety of Sanofi Pasteur's CYD Dengue Vaccine in Healthy Children and Adolescents in Latin America (NCT00993447) | Sanofi Pasteur, a Sanofi Company | 2009-10-01 |
| Clinical Evaluation of Insect Repellent and Insecticide Treated Nets in Lao PDR (NCT00938379) | London School of Hygiene and Tropical Medicine | 2009-07-01 |
| Safety of and Immune Response to a Dengue Virus Vaccine (rDEN3-3'Ddelta30) in Healthy Adults (NCT00712803) | National Institute of Allergy and Infectious Diseases (NIAID) | 2008-12-01 |
| The Effect of Chloroquine in the Treatment of Patients With Dengue (NCT00849602) | University of Sao Paulo | 2008-02-01 |
| Follow-up the Health Condition , Investigation of the Immuno-regulation , and the Study for Interaction of Viral Hepatitis--- Among Patients With or After Dengue Fever Infection (NCT00629356) | Kaohsiung Medical University Chung-Ho Memorial Hospital | 2007-07-01 |
| A Phase II Trial of a Live Attenuated Virus Tetravalent Dengue Vaccine in Healthy Adults in Thailand (NCT00370682) | U.S. Army Medical Research and Development Command | 2007-04-01 |
| Safety of and Immune Response to a Dengue Virus Vaccine (rDEN4delta30-4995) in Healthy Adults (NCT00322946) | National Institute of Allergy and Infectious Diseases (NIAID) | 2007-01-01 |
| Safety of and Immune Response to a Dengue Virus Vaccine (rDEN3/4delta30[ME]) in Healthy Adults (NCT00375726) | National Institute of Allergy and Infectious Diseases (NIAID) | 2006-10-01 |
| Prospective Study of Infant Dengue (NCT00377754) | National Institute of Allergy and Infectious Diseases (NIAID) | 2006-09-01 |
| Study of ChimeriVax™ Dengue Tetravalent Vaccine in Adult Subjects (NCT00730288) | Sanofi | 2006-08-01 |
| Implementation Research of New Dengue Vector Control Tools (NCT00883441) | Institute of Tropical Medicine, Belgium | 2006-07-01 |
| Safety and Immunogenicity of Various Formulations of Live Attenuated Tetravalent Dengue Vaccine in Healthy US Adults (NCT00350337) | U.S. Army Medical Research and Development Command | 2006-04-05 |
| A Trial of a Walter Reed Army Institute of Research (WRAIR) Live Attenuated Virus Tetravalent Dengue Vaccine in Healthy US Adults (NCT00239577) | GlaxoSmithKline | 2006-04-05 |
| Safety and Immunogenicity Study of a Dengue Virus DNA Vaccine (NCT00290147) | U.S. Army Medical Research and Development Command | 2006-01-01 |
| A Phase I/II Trial of Tetravalent Live Attenuated Dengue Vaccine in Flavivirus Antibody Naive Infants (NCT00322049) | U.S. Army Medical Research and Development Command | 2004-02-01 |